切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2019, Vol. 05 ›› Issue (04) : 359 -363. doi: 10.3877/cma.j.issn.2096-1537.2019.04.012

所属专题: 文献

综述

生物标志物对急性胰腺炎严重程度的早期预测
贾媛媛1, 赵冰1, 马丽1, 陈影1, 盛慧球1, 毛恩强1, 陈尔真1,()   
  1. 1. 200025 上海交通大学医学院附属瑞金医院急诊科
  • 收稿日期:2018-12-31 出版日期:2019-11-28
  • 通信作者: 陈尔真
  • 基金资助:
    国家自然科学基金资助项目(81772107); 上海市科学技术委员会科研计划项目(18411966400); 上海市卫生计生系统重要薄弱学科建设计划任务书(2016ZB0206)

Advance of biological markers in study on early prediction value of acute pancreatitis

Yuanyuan Jia1, Bing Zhao1, Li Ma1, Ying Chen1, Huiqiu Sheng1, Enqiang Mao1, Erzhen Chen1,()   

  1. 1. Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Received:2018-12-31 Published:2019-11-28
  • Corresponding author: Erzhen Chen
  • About author:
    Corresponding author: Chen Erzhen, Email:
引用本文:

贾媛媛, 赵冰, 马丽, 陈影, 盛慧球, 毛恩强, 陈尔真. 生物标志物对急性胰腺炎严重程度的早期预测[J/OL]. 中华重症医学电子杂志, 2019, 05(04): 359-363.

Yuanyuan Jia, Bing Zhao, Li Ma, Ying Chen, Huiqiu Sheng, Enqiang Mao, Erzhen Chen. Advance of biological markers in study on early prediction value of acute pancreatitis[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2019, 05(04): 359-363.

急性胰腺炎是全球范围内三大消化道疾病之一,根据其严重程度可分为轻度急性胰腺炎、中度重症急性胰腺炎、重度急性胰腺炎。中、重度急性胰腺炎病情重、进展迅速、病死率高。早期识别急性胰腺炎严重程度并尽早加强护理与治疗,可改变患者病程、住院时间及病死率。生物标志物具有标本容易获取、检测重复性好、稳定性高等优点,寻找有效的早期评估急性胰腺炎病情的生物标志物有助于胰腺炎的诊疗。本文就生物标志物对急性胰腺炎严重程度的早期预测研究进展做一综述。

Acute pancreatitis is one of the three most important diseases of the digestive system in the worldwide. It can be categorized into mild acute pancreatitis (MAP), moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP). MSAP and SAP are severe, rapid progress and high mortality disease. Early recognition of the severity of pancreatitis and early appropriate care can change the course of disease, short the hospital stay and reduce mortality. Biological markers have attracted much attention due to their accessibility, high reproducibility and stability. Finding out the effective biomarkers for early assessment of acute pancreatitis is helpful for diagnosis and treatment. We reviewed the advances of biological marker for AP severity early prediction.

1
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus [J]. Gut, 2013, 62(1): 102-111.
2
Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute Guidelineon Initial Management of Acute Pancreatitis [J]. Gastroenterology, 2018, 154(4): 1096-1101.
3
Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018 [J]. Gastroenterology, 2018. DOI: 10.1053/j.gastro.2018.08.063.
4
Hazra N, Gulliford M. Evaluating pancreatitis in primary care: a population-based cohort study [J]. Br J Gen Pract, 2014, 64(622): e295-301.
5
Zahorec R. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress incritically ill [J]. Bratisl Lek Listy, 2001, 102(1): 5-14.
6
Shen Y, Cui N, Miao B, et al. Immune dysregulation in patients with severe acute pancreatitis [J]. Inflammation, 2011, 34(1): 36-42.
7
Pinhu L, Qin Y, Xiong B, et al. Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes [J]. Inflammation, 2014, 37(4): 1202-1212.
8
Qi X, Yang F, Huang H, et al. A reduced lymphocyte ratio as an early marker for predicting acute pancreatitis [J]. Sci Rep, 2017, 7: 44087.
9
Jeon TJ, Park JY. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis [J]. World J Gastroenterol, 2017, 23(21): 3883-3889.
10
Nigro KG, O′Riordan M, Molloy EJ, et al. Performance of an automated immature granulocyte count as a predictor of neonatal sepsis [J]. Am J Clin Pathol, 2005, 123(4): 618-624.
11
Zhu Y. Tumor necrosis factor-α and procalcitonin level variations in the serum and their effects on organ function in patients with severe acute pancreatitis during infected stage [J]. Pak J Pharm Sci, 2017, 30(4Suppl): 1413-1416.
12
Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant [J]. Eur J Biochem, 1999, 265(2): 501-523.
13
Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states [J]. Curr Opin Hematol, 2000, 7(1): 64-69.
14
曹永献, 孙桂荣, 孙秀芳. 联合检测血清淀粉样蛋白A和C-反应蛋白对重症急性胰腺炎早期预测的临床意义 [J]. 临床内科杂志, 2008, 25(8): 553-554.
15
谷小玉, 黄尚书, 梁伟新, 等. SAA、NLR预测急性胰腺炎严重程度的价值 [J]. 中国医药导报, 2018, 15(16): 63-66.
16
Holwerda DA. Glycopeptide from the posterior lobe of pig pituitaries. isolation and characterization [J]. Eur J Biochem, 1972, 28(3): 334-339.
17
Urwyler SA, Schuetz P, Sailer C, et al. Copeptin as a stress marker prior and after a written examination--the CoEXAM study [J]. Stress, 2015, 18(1): 134-137.
18
Fenske W, Refardt J, Chifu I, et al. A copeptin-based approach in the diagnosis of diabetes insipidus [J]. N Engl J Med, 2018, 379(5): 428-439.
19
Lee JH, Chan YH, Lai OF, et al. Vasopressin and copeptin levels in children with sepsis and septic shock [J]. Intensive Care Med, 2013, 39(4): 747-53.
20
Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis [J]. Crit Rev Clin Lab Sci, 2015, 52(6): 273-283.
21
Sang G, Du JM, Chen YY, et al. Plasma copeptin levels are associated with prognosis of severe acute pancreatitis [J]. Peptides, 2014, 51: 4-8.
22
Isman FK, Zulfikaroglu B, Isbilen B, et al. Copeptin is a predictive biomarker of severity in acute pancreatitis [J]. Am J Emerg Med, 2013, 31(4): 690-692.
23
Sendler M, Weiss FU, Golchert J, et al. Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice [J]. Gastroenterology, 2017, 154(3): 704-718.
24
Talukdar R, Sareen A, Zhu H, et al. Release of cathepsin-B in cytosol causes cell death in acute pancreatitis [J]. Gastroenterology, 2016, 151(4): 747-758. e5.
25
Gabrilovich D, Nefedova Y. ROR1C regulates differentiation of myeloid-derived suppressor cells [J]. Cancer Cell, 2015, 28(2): 147-149.
26
Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity [J]. Blood, 2008, 111(8): 4233-4244.
27
Uhel F, Azzaoui I, Grégoire M, et al. Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis [J]. Am J Respir Crit Care Med, 2017, 196(3): 315-327.
28
Samir M, Vaas LA, Pessler F. MicroRNAs in the host response to viral infections of veterinary importance [J]. Front Vet Sci, 2016, 3: 86.
29
Wei Q, Sun H, Song S, et al. MicroRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury [J]. J Clin Invest, 2018, 128(12): 5448-5464.
30
Braunwald E. The war against heart failure: the Lancet lecture [J]. Lancet, 2015, 385(9970): 812-824.
31
Patel M, Verma A, Aslam I, et al. Novel plasma microRNA biomarkers for the identifi cation of colitis-associated carcinoma [J]. Lancet, 2015, 385(Suppl1): S78.
32
Kuśnierz-Cabala B, Nowak E, Sporek M, et al. Serum levels of unique miR-551-5p and endothelial-specific miR-126a-5p allow discrimination of patients in the early phase of acute pancreatitis [J]. Pancreatology, 2015, 15(4): 344-351.
33
Liu S, Zou H, Wang Y, et al. miR-155-5p is negatively associated with acute pancreatitis and inversely regulates pancreatic acinar cell progression by targeting Rela and Traf3 [J]. Cell Physiol Biochem, 2018, 51(4): 1584-1599.
34
Song L, Wörmann S, Ai J, et al. BCL3 reduces the sterile inflammatory response in pancreatic and biliary tissues [J]. Gastroenterology, 2016, 150(2): 499-512.e20.
35
Criddle DN. Reactive oxygen species, Ca2+ stores and acute pancreatitis; a step closer to therapy? [J]. Cell Calcium, 2016, 60(3): 180-189.
36
Manohar M, Verma AK, Venkateshaiah SU, et al. Pathogenic mechanisms of pancreatitis [J]. World J Gastrointest Pharmacol Ther, 2017, 8(1): 10-25.
37
Pan MG, Xiong Y, Chen F. Nfat gene family in inflammation and cancer [J]. Curr Mol Med, 2013, 13(4): 543-554.
38
Norberg KJ, Nania S, Li X, et al. RCAN1 is a marker of oxidative stress, induced in acute pancreatitis [J]. Pancreatology, 2018, 18(7): 734-741.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 杨桂清, 孟静静. 哺乳期亚临床乳腺炎的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 376-379.
[3] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4] 党军强, 杨雁灵, 汪庆强, 尚琳, 朱磊, 项红军. 主动经皮穿刺引流治疗重症急性胰腺炎并发急性坏死物积聚的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 671-674.
[5] 刘中文, 刘畅, 高洋, 刘东, 林世庆, 杨建华, 赵福义. 尿液microRNA-326与腹腔镜根治性膀胱切除术治疗膀胱癌患者预后的相关性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 386-391.
[6] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[7] 罗霞, 王宝梅, 李淑景, 杨英. 特发性肺动脉高压血清PCSK9表达及预后意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 585-589.
[8] 甘志新, 胡雍军, 肖晶, 胡明冬. 降钙素原在脓毒血症与肺部感染中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 663-666.
[9] 冯熔熔, 苏晓乐, 王利华. 慢性肾脏病患者并发心血管疾病相关生物标志物研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 273-278.
[10] 史清泉, 苗彬, 王烁, 陶琳, 沈晨. miR-181a-5p 靶向ATG5 抑制雨蛙素诱导的大鼠胰腺腺泡细胞AR42J自噬的机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 524-530.
[11] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[12] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[13] 杨爽, 余宏亮, 谢敏. CT 与超声检查对急性胰腺炎合并脂肪肝的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 541-544.
[14] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[15] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?